Nimesulide in the Treatment of Pelvic Inflammatory Diseases
- 9 Downloads
400 patients aged 18 to 71 years took part in a multicentre noncomparative study designed to assess the clinical efficacy and tolerability of nimesulide in gynaecological inflammatory disease: adnexitis (72 patients), cervicitis (78 patients), endometritis (18 patients), myometritis (22 patients), and combined disorders (210 patients). All patients were treated with nimesulide 100mg twice daily in granular form for an average of 19.5 days. The treatment produced good results in all types of diseases considered, with a significant decrease in severity of symptoms being observed. The drug was well tolerated.
KeywordsLide Urticaria Nimesulide Pelvic Inflammatory Disease Female Genital Tract
Unable to display preview. Download preview PDF.
- Gallo MF, Romiti A, Giacovazzo M, Dal Prà ML. La nimesulide nella terapia della cefalea catameniale. Farmaci e Terapia 5: 52–55, 1988Google Scholar
- Pulkkinen MO. The effect of nimesulide on intrauterine pressure in dysmenorrhoeic women. Drugs under Experimental and Clinical Research 10: 599–606, 1984Google Scholar